Cargando…

Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine

Live attenuated viral vaccine/vector candidates are inherently unstable and infectivity titer losses can readily occur without defining appropriate formulations, storage conditions and clinical handling practices. During initial process development of a candidate vaccine against HIV-1 using a recomb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumru, Ozan S., Saleh-Birdjandi, Soraia, Antunez, Lorena R., Sayeed, Eddy, Robinson, David, van den Worm, Sjoerd, Diemer, Geoffrey S., Perez, Wilma, Caposio, Patrizia, Früh, Klaus, Joshi, Sangeeta B., Volkin, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863464/ https://www.ncbi.nlm.nih.gov/pubmed/31548012 http://dx.doi.org/10.1016/j.vaccine.2019.09.027

Ejemplares similares

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration
por: Hu, Yue, et al.
Publicado: (2020)

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
por: Kumru, Ozan S., et al.
Publicado: (2023)

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery
por: Kumar, Prashant, et al.
Publicado: (2021)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018(TM) Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
por: Bajoria, Sakshi, et al.
Publicado: (2023)

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
por: Kumar, Prashant, et al.
Publicado: (2023)

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
por: Kumar, Prashant, et al.
Publicado: (2022)

Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation
por: Crawford, Lindsey B., et al.
Publicado: (2022)

Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34(+) Hematopoietic Progenitor Cells from Apoptosis
por: Hancock, Meaghan H., et al.
Publicado: (2021)

Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
por: Bajoria, Sakshi, et al.
Publicado: (2022)

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array
por: Wan, Ying, et al.
Publicado: (2018)

Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch(TM) Microneedle Delivery System
por: Wan, Ying, et al.
Publicado: (2021)

Cloning, Assembly, and Modification of the Primary Human Cytomegalovirus Isolate Toledo by Yeast-Based Transformation-Associated Recombination
por: Vashee, Sanjay, et al.
Publicado: (2017)

Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency
por: Caviness, Katie, et al.
Publicado: (2016)

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
por: Teh, Audrey Y-H, et al.
Publicado: (2021)

The Differentiation of Human Cytomegalovirus Infected-Monocytes Is Required for Viral Replication
por: Min, Chan-Ki, et al.
Publicado: (2020)

Human Cytomegalovirus Infection Suppresses CD34(+) Progenitor Cell Engraftment in Humanized Mice
por: Crawford, Lindsey B., et al.
Publicado: (2020)

Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice
por: Crawford, Lindsey B., et al.
Publicado: (2017)

Characterization of a live-attenuated HCMV-based vaccine platform
por: Caposio, Patrizia, et al.
Publicado: (2019)

Late gene expression–deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV
por: Hansen, Scott G., et al.
Publicado: (2023)

Crystallization of a nonreplicating rotavirus vaccine candidate
por: Hong, Moo Sun, et al.
Publicado: (2021)

Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation
por: Crawford, Lindsey B., et al.
Publicado: (2018)

Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
por: Kaur, Kawaljit, et al.
Publicado: (2021)

Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter Infection
por: Perruzza, Lisa, et al.
Publicado: (2020)

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2022)

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023)

Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023)

Human Cytomegalovirus-Encoded pUL7 Is a Novel CEACAM1-Like Molecule Responsible for Promotion of Angiogenesis
por: MacManiman, Jason D., et al.
Publicado: (2014)

A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
por: Tsuda, Yoshimi, et al.
Publicado: (2011)

Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells
por: Lee, Byeong-Jae, et al.
Publicado: (2021)

Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34(+) Hematopoietic Progenitor Cells and Humanized NSG Mice
por: Crawford, Lindsey B., et al.
Publicado: (2019)

A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
por: Lee, Shwu-Maan, et al.
Publicado: (2020)

Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Signal Peptide-Dependent Inhibition of MHC Class I Heavy Chain Translation by Rhesus Cytomegalovirus
por: Powers, Colin J., et al.
Publicado: (2008)

A Novel Human Cytomegalovirus Locus Modulates Cell Type-Specific Outcomes of Infection
por: Umashankar, Mahadevaiah, et al.
Publicado: (2011)

Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus
por: Xiao, Yuhong, et al.
Publicado: (2020)

Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

BST2/Tetherin Enhances Entry of Human Cytomegalovirus
por: Viswanathan, Kasinath, et al.
Publicado: (2011)

Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0chmhb9pe2182g7e976o6bagjd